Insight Molecular Diagnostics Inc. is rated Hold due to upcoming catalysts & pending FDA submission for GraftAssureDx. Read ...
Integrating Git version control with validation systems automates medical device software traceability, ensuring instant ...
On track to submit GraftAssureDx™ for FDA review by year-endOn track for commitment to have 20 transplant centers globally ...
Learn how data management strategies for design for manufacturing initiatives can also promote overall operational excellence ...
Building a medtech startup is a long, costly, and often unforgiving journey. Most don’t make it past five years ...
The South Korean industry, previously considered a latecomer in the field of artificial intelligence (AI)-based drug ...
Q3 2025 Earnings Call Transcript November 13, 2025 Operator: Greetings, and welcome to the HeartBeam Third Quarter 2025 ...
Q3 2025 Earnings Call November 14, 2025 5:00 PM ESTCompany ParticipantsAdarsh Parekh - Chief Financial OfficerCarol Craig ...
CHESTERFIELD, Mo., Nov. 12, 2025 /PRNewswire/ -- HCFS, the industry leader in healthcare claims and audit technology, announced the launch of RecordPlus (TM), a breakthrough system designed to ...
With the rapid advancements in computer technology and bioinformatics, the prediction of protein-ligand binding sites has ...
At the 2025 World Internet Conference in Wuzhen, the global spotlight once again turned to this picturesque water town in southern China, as leaders from the internet and technology innovation sectors ...
Strata Critical Medical, Inc. (NASDAQ: SRTA) Q3 2025 Earnings Call Transcript November 10, 2025 Strata Critical Medical, Inc. beats earnings expectations. Reported EPS is $0.696, expectations were $-0 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback